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Abstract
Objective—The objective of this study was to assess the conditions under which Zambia women 
with a history of cervical cancer screening by visual inspection with acetic acid might switch to 
HPV-based testing in the future.
Methods—We conducted a choice-based conjoint survey in a sample of women recently 
screened by visual inspection in Lusaka, Zambia. The screening attributes considered in 
hypothetical choice scenarios included: screening modality, sex and age of the examiner, whether 
screening results would be presented visually, distance from home to the clinic, and wait time for 
results.
Results—Of 238 women in the sample, 208 (87.4%) provided responses sufficiently reliable for 
analysis. Laboratory testing on a urine sample was the preferred screening modality, followed by 
visual screening, laboratory testing on a self-collected vaginal specimen, and laboratory testing on 
a nurse-collected cervical specimen. Market simulation suggested that only 39.7% (95% 
confidence interval, 33.8, 45.6) of respondents would prefer urine testing offered by a female 
nurse in her 30's over visual inspection of the cervix conducted by a male nurse in his 20's if extra 
wait time were as short as one hour and the option of viewing how their cervix looks like were not 
available.
Conclusion—Our study suggests that, for some women, level of preference for HPV-based 
screening strategies may depend highly on the process and conditions of service delivery.
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Introduction
The Cervical Cancer Prevention Program in Zambia (CCPPZ) is the largest cervical cancer 
prevention program linked to HIV care in sub-Saharan Africa.1,2 The screening strategy is 
currently based on visual inspection of the cervix with acetic acid, supplemented by digital 
photographic images acquired using a commercial brand digital camera. Women who screen 
positive are offered immediate cryotherapy, if eligible. Repeated screening is recommended 
one year after treatment for a cervical abnormality or in three years otherwise.
One option for scaling up cervical cancer prevention services in Zambia is the use of HPV 
DNA-based screening.1 An important question for the program is therefore to determine the 
conditions under which women, and in particular high-risk women, might elect to undergo 
HPV testing in the future.
Choice-based conjoint methodology is a powerful tool to assess patients’ preferences for 
modifiable aspects of health care, including new services and innovations in service 
delivery.3,4 The approach is based on the premise that any product can be described with a 
set of attributes important to the target population and that a person's overall preference for a 
particular product is driven by their relative preference for the combination of attributes of 
this product compared to that of the other products available.
In this study we used choice-based conjoint methodology to investigate the preferences of 
Zambia women recently screened by visual inspection for a range of clinic-based screening 
alternatives built around key attributes of visual screening and HPV testing. We also aimed 




This study was embedded within a larger qualitative and quantitative study of women's 
experience with cervical cancer screening conducted at Kanyama clinic.5,6 Located in the 
outskirt of Lusaka, this government-run health center provides a wide range of preventive 
and curative services to the surrounding community, including cervical cancer preventive 
care, and HIV, maternal and child care. Cervical cancer screening is currently available 
every week day, free of charge. Peer educators visit the clinic waiting rooms in the early 
morning to offer visual cervical screening to all women aged 18-49 years and refer those 
who accept to the screening nurse. Screening results are immediately communicated to the 
woman through the use of the magnified digital picture of their cervix. In 2011, an average 
of 10-15 women were examined each day. Of those 1-to-3 had indications for immediate 
treatment of cervical abnormality by cryotherapy.
Chamot et al. Page 2













For the main study, we recruited a consecutive sample of 300 women who consented to 
participate and undergo screening. All women were invited to complete three face-to-face 
interviews. The first interview took place immediately before screening, the second 
immediately after screening, and the third 6-to-8 weeks later, when women diagnosed with a 
cervical abnormality were scheduled for early follow-up. Participants in the choice-based 
conjoint sub-study (hereafter referred to as stated choice survey) were the subset of 238 
women who completed the third interview. Socio-demographic, locator, and medical record 
data were obtained from the screening team. Participants had no history of cervical cancer 
screening or treatment for cancer of the cervix.
Study protocol was approved by research ethics committees from the University of Alabama 
at Birmingham and the University of Zambia. The Zambia Ministry of Health authorized the 
study to be conducted in a government clinic.
Choice-based conjoint survey
In the stated preference surveys the least challenging and most natural for respondents, each 
participant is presented with a brief set of discrete choice questions; each question compares 
the attributes of two products; and participants are asked to indicate for each question the 
product they prefer. In this study, the “products” were two hypothetical screening clinics 
described in terms of multi-option attributes describing the cervical cancer screening 
services offered. For each question, the respondent was asked to which clinic they would 
choose to go.
Attributes retained for the study were: (1) visual screening or laboratory testing modalities, 
described solely in terms of visual inspection (yes or no), biological specimen (cervical/
vaginal sample, urine sample, or neither), and method of specimen collection (nurse-
collected or self-collected); (2) examiner, defined by their gender and age; (3) option to view 
a digital picture of one's cervix; (4) travel distance to the clinic; and (5) wait time to receive 
screening results (Table 1).
The process of survey development involved a review of the literature, consultations with 
six Zambian and foreign experts, and eight focus group discussions with women and 
screening personnel.5,6 We also conducted extensive field testing in local languages to 
ensure that choice questions were relevant and understood by the respondents. Because the 
study included low-literacy women, the number of attributes was limited to five and the 
maximum number of attribute options to four. We did not retain screening fee as an 
attribute, because cervical cancer screening is offered free of charge in Zambia. Since some 
scenarios did not involve a speculum examination, participants were told that they would be 
presented with a “picture of how they cervix looks like”; however, as a shorthand, we will 
refer to this attribute using the expression ”picture of one's cervix”.
Data collection
Stated choice data were collected face-to-face using laptop computer-aided technology (SSI 
Web 6.6.2, Sawtooth Software, Sequin, WA). All participants were interviewed privately in 
the language of their choice by trained female interviewers of the same cultural background. 
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Interviewers introduced the stated choice survey with the following statement: “The method 
currently available at Kanyama Clinic to detect sores of the “mouth of the womb” is called 
visual screening. Within the next few years new methods should become available. We 
would like to know which methods women like you might prefer in the future and why.” For 
clarity's sake, the steps of visual cervical screening were briefly reviewed and compared to 
those of the “new laboratory testing methods”. Then, the interviewer read the automatically-
generated choice questions one at a time, making sure that the computer screen was in the 
respondent's sight.
Four attributes including four response options and one attribute including two response 
options could be combined into 512 different pairs of clinic profiles and as many choice 
questions. To reduce the number of questions submitted to each participant to a statistically 
appropriate subset, we opted for a full-profile, balanced overlap, computer randomized 
design,4,7 where each woman was presented with a set of 8 randomly-generated questions 
and 2 fixed, validation questions. Pilot testing indicated that 10 choice questions was the 
maximum number that women would respond to before getting tired. The balanced overlap 
design allows investigators to determine if respondents’ preference weights for the options 
of an attribute depend on the option presented for another attribute (i.e., interaction between 
attributes).8
Statistical analysis
We used hierarchical Bayes (HB) random-effects logit modeling to estimate an importance 
score for each attribute, that is an indicator of the relative influence of an attribute on choice 
decisions for a clinic expressed in percent of the combined influence of all the attributes 
(Sawtooth CBC/HB software version 4.6.4).9 For each attribute, we calculated the 
proportion of respondents who selected a particular option as their preferred option, 
controlling for the other attributes. Model-derived preference scores of each individual 
woman for each one of the attribute option in the study were expressed as zero-centered 
difference scores. A property of these scores is that, for each attribute, the range of mean 
scores for the different options of the attribute reflects the importance of this attribute 
relative to that of the other attributes.10 Finally we used a market simulator (Sawtooth 
SMRT version 4.20.2)11 to predict participants’ sensitivity to increasing wait time when 
comparing preferences for laboratory-based options to visual cervical screening as currently 
offered.
Results
Choice-based interviews were carried out between January and June 2011. Of 238 women 
who presented for the third interview (79.3% of baseline sample), 237 (99.6%) successfully 
completed the stated choice survey. All of them were comfortable with the idea of possibly 
undergoing cervical screening again in the future. Mean time to complete the survey was 
13.4 minutes (SD, 5.6). HB analysis indicated that preferences for an attribute did not 
meaningfully influence preferences for another attribute (e.g., the characteristics of the 
examiners did not substantially influence preferences for screening modality). We restricted 
further analyses to the 208 women (87.4%) who provided sufficiently reliable responses to 
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the choice questions (root likelihood fit score ≥ 800) .12 Among these women, the HB model 
correctly predicted 396 (95.2%) of the 416 responses to the fixed, validation questions.
Mean age of women retained for analysis was 32 years (SD, 8); 141 (68%) were married; 
102 (49%) had primary school education or less; 129 (62%) had a monthly household 
income ≤ $45 (ZMK, 200,000); and 19 (9%) had formal employment. Eighty (38.5%) were 
HIV-infected (all but 2 on antiretroviral therapy), 76 (36.5%) were HIV-uninfected, and 52 
(25.0%) had an unknown HIV status. Visual screening results were abnormal for 29 women: 
17 HIV infected women (prevalence, 21.3%; 95% CI, 13.3, 31.2), 7 HIV uninfected women 
(prevalence, 9.2%; 95% CI, 4.1, 17.4), and 5 women with unknown HIV status (prevalence, 
9.6%; 95% CI, 3.6, 20.0; chi-square test, P=0.05).
In terms of relative influence of attributes on choice of clinics, respondent gave highest 
importance to wait time (37.4% of total influence; 95% CI, 35.3, 39.5), followed by 
examiner (25.1%; 95% CI, 21.7, 28.5), picture of one's cervix (18.7%; 95% CI, 15.6, 21.8), 
screening modality (10.9%; 95% CI, 10.2, 11.7), and distance from home (7.8%; 95% CI, 
6.8, 8.9; P<0.001).
All other attribute options being equal, the vast majority of women (87.5%) preferred to 
receive screening results immediately (Table 2). Even waiting as little as one hour resulted 
in a 58.4 point drop in mean preference score (Figure 1). A 3-day wait resulted in 181.3 
point drop. Most women preferred a female nurse (88.9%) over a male nurse (11.1%). Age 
had much less importance in determining the attractiveness of a nurse than gender. All 
women but two wished to view a picture of their cervix. Urine testing was the screening 
option most frequently preferred by respondents (51%); the other three options were 
preferred by equivalent proportions of women (12.5%-to-20.2%). Similarly, in comparison 
with the estimates obtained for the three previous attributes, differences in mean preference 
scores for the screening modalities were small (21.2 points or less; Figure 1). Finally, after 
accounting for the other attributes, equally large proportions of women preferred a 15-
minute bus ride (43%), or to walk 10 minutes (42%), to go from home to the screening 
clinic. Difference in mean preference score between the most attractive option (15-minute 
bus trip) and the least attractive option (20-minute walk) was only 14.3 points.
Market simulations predicted that if participants had to choose between laboratory testing of 
a self-collected vaginal specimen (without presentation of a cervicogram) and visual cervical 
screening as currently performed (with presentation of a cervicogram), holding the examiner 
and travel distance attributes constant, then only 11.5% (95% CI, 8.1, 14.9) would opt for 
laboratory testing if results were available immediately, 1.5% (95% CI, 0.7, 2.3) if wait time 
were 1 hour, and 0.8% (95% CI, 0.0, 1.6) if wait time were 3 days. If testing of a urine 
specimen were proposed instead of testing a self-collected vaginal sample, the 
corresponding shares barely increased to 14.1% (95% CI, 11.1, 17.1; results immediately 
available), 3.8% (95% CI, 2.2, 5.4; 1-hour wait), and 2.2% (95% CI, 0.6, 3.9; 3-day wait). 
Finally, in a scenario were the examiner proposing laboratory testing would be a female in 
her 30s and the visual examiner a male in his 20s, simulations predicted that 54.7% (95% 
CI, 48.7, 60.7) of participants would chose laboratory testing of a urine sample if results 
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were available immediately, 39.7% (95% CI, 33.8, 45.6) if wait time were 1 hour, and 
22.1% (95% CI, 16.9, 27.3) if wait time were 3 days.
Discussion
In this study, a majority of Zambia women with recent history of screening by visual 
inspection indicated that for future screening, and all other factors being equal, they would 
prefer visual screening aided by digital cervicography over clinic-based laboratory testing 
alternatives not coupled with the option of viewing how their cervix looks. Although urine 
testing was in itself the preferred screening modality for most women, their hypothetical 
choice decisions were more heavily influenced by wait time and mode of communication of 
screening results than by the degree of privacy and invasiveness of the screening method. 
Since our results support the notion that none of the HPV detection methods currently 
available, or in development will be automatically considered ideal by all women, they have 
implications for implementation of new World Health Organization HPV screening 
guidelines13 in areas where screening programs based on visual inspection methods are 
already in place.
A distinct advantage of HPV tests from an acceptability perspective is the possibility to 
avoid speculum examination if testing is performed on a self-collected vaginal sample and 
results are negative.14 Acceptability of self-sampling is typically high in both developed and 
developing countries,14,15 especially among affluent and well-educated women.16 In some 
settings, however, many women declare having more trust in clinician sampling than in self-
sampling because they do not have to worry about collecting the vaginal specimen 
properly.15,16 In our study, and after adjustment for screening process and service delivery 
variables, women experienced with visual cervical screening gave similar and relatively low 
preference scores to testing of self-collected samples, testing of nurse-collected samples, and 
screening by visual inspection.
HPV testing in urine samples would be easier and, as suggested by our study and others, 
more acceptable to women than HPV testing in self-collected vaginal samples.17 However, 
in our market simulations, HPV testing was nearly consistently dominated by visual cervical 
screening augmented with digital cervicography when HPV test results were communicated 
without pictorial aid. For instance, this was the case even under the assumptions that the 
examiner would be a male- rather than a female nurse, and that time spent at the clinic 
would be increased by one hour only.
An appealing screening option not considered in this study is that of community-based 
screening by HPV testing of vaginal specimen self-collected at home.14 However, further 
evaluation of this approach is needed as past studies suggest that women's preference for 
self-sampling at home or at the clinic might vary across settings.18-20 For instance, in a 
Uganda study, lack of privacy at home was cited as a barrier to self-sampling.19 In Italy, 
direct mailing of a self-sampling kit to women who failed to respond to a screening 
invitation increased screening coverage in urban areas, but not in rural areas.20
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A limitation of our study is that women never screened for cervical cancer were excluded. 
Although these women might have had different preferences, pilot testing suggested that 
most of them would not have been able to provide reliable responses to the choice questions. 
Finally, for the sake of limiting participant burden, test accuracy was not included among 
the attributed to be evaluated. Accounting for the superior accuracy of HPV testing over 
screening by visual inspection might have influenced the balance of women's preference 
between test options.
Conclusion
The factors that drive women's preferences for a particular cervical cancer screening option 
are complex and variable. Although recent advances in HPV testing offer the perspective of 
widening access to cervical cancer prevention in resource-limited settings, to be successful 
at a population level, HPV-based screening programs will need to continue paying great 
attention to obstacles to participation beyond discomfort and embarrassment.
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In Zambia, women's preference for cervical screening based on HPV testing rather than 
visual inspection is contingent on wait time and method of result communication.
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Figure 1. Mean preference scores (95% confidence intervals) for the options of each attribute
“min”=minute, “h”=hour, “d”=day, “F 30s”=female in her 30s, “F 20s”=female in her 20s, 
“M 30s”=male in his 30s, “M 20s”=male in his 20s”, “visual”=visual inspection with acetic 
acid, “self”=self-collected vaginal specimen, “nurse”=nurse-collected vaginal specimen.
Note: Attributes are ordered by decreasing importance from the left to the right. Preference 
scores are expressed as zero-centered difference scores to reduce differences in 
measurement scale among the attributes. In this interval metric, the sum of the mean 
preference scores of all the options of an attribute is always equal to zero. Individual scores 
have no meaningful interpretations; only differences between scores are interpretable.
Chamot et al. Page 10

























Chamot et al. Page 11
Table 1
Clinic attributes and attribute options used to compose choice questions
Attribute Attribute options
Screening modality • Gynecologic exam and visual inspection: This is the test currently available. You have to undress for a 
gynecological exam; the wounds of the cervix are detected by visual inspection.
• Gynecologic exam and swab of the cervix collected by a nurse: You have to undress for a gynecological exam; 
the nurse gently rubs your cervix with a cotton swab to collect some fluid, but does not put vinegar on your cervix; 
the cotton swab is sent to the laboratory for analysis.
• Swab of the virginal privately collected by the woman herself: There is no gynecological exam unless test result 
is abnormal. You undress, alone in a small room; you introduce a cotton swab in your virginal and rotate it several 
times to collect fluid; then you remove the swab from the virginal and places it in a small tube; the tube is sent to 
the laboratory for analysis.
• Urine sample privately collected by the woman herself: There is no gynecological exam unless screening result 
is abnormal. You undress alone in the bathroom; you pee and collect a little amount of urine in a plastic container; 
the container is sent to the laboratory for analysis.
Nurse taking care of you • A female nurse in her twenties
• A male nurse in his twenties
• A female nurse in her thirties
• A male nurse in his thirties
To discuss screening 
results with you...
• Picture: The nurse shows you a picture of how your cervix looks like.
• No picture: The nurse does not show you a picture of how your cervix looks like.
Distance of the screening 
clinic from home
• 10-minute walk: A mobile screening clinic comes in your neighborhood; you need to walk 10 minutes from 
home to the clinic.
• 20-minute walk: You need to walk 20 minutes from home to the nearest screening clinic.
• 15-minute bus trip: It takes you a 15-minute ride by bus to go from home to the nearest screening clinic.
• 30-minute bus trip: It takes you a 30-minute ride by bus to go from home to the nearest screening clinic.
Waiting time for results • No wait: You do not have to wait at the clinic; the screening result is immediately available.
• 1-hour wait: You have to wait 1hour at the clinic until your screening result is back.
• 4-hour wait: You have to wait 4 hours at the clinic until your screening result is back.
• 3-day wait: You have to come back to the clinic 3 days later to learn about your screening result.
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Table 2
Number and percentage of women preferring each attribute option
Attribute Preferred option
Number of women (N=208) Percent (95% CI)
Wait time
    No wait time 182 87.5 (82.5, 91.5)
    1 hour 17 8.2 (5.0, 12.5)
    4 hours 4 1.9 (0.6, 4.6)
    3 days 5 2.4 (0.9, 5.3)
Picture
    Yes 206 99.0 (96.9, 99.8)
    No 2 1.0 (0.2, 3.1)
Nurse
    Female in her 30s 107 51.4 (44.7, 58.2)
    Female in her 20s 78 37.5 (31.1, 44.2)
    Male in his 30s 4 1.9 (0.6, 4.6)
    Male in his 20s 19 9.1 (5.8, 13.7)
Screening modality
    Urine sample 106 51.0 (44.2, 57.7)
    Visual inspection 34 16.4 (11.8, 21.8)
    Self-collected swab 42 20.2 (15.2, 26.1)
    Nurse-collected swab 26 12.5 (8.5, 17.5)
Distance from home
    15-minute bus trip 90 43.3 (36.7, 50.1)
    10-minute walk 88 42.3 (35.7, 49.1)
    30-minute bus trip 21 10.1 (6.5, 14.8)
    20-minute walk 9 4.3 (2.1, 7.8)
Attributes (attribute options) are listed by decreasing order of importance (mean preference).
SD stands for standard deviation and 95% CI for 95 percent exact mid-P confidence interval.
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